One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-140314
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 9 |
Affiliation: The Ohio State University Wexner Medical Center, Institut Català d'Oncologia, The Maria Sklodowska-Curie National Research Institute of Oncology, University of Perugia, Ronald Reagan UCLA Medical Center, Semmelweis University, University Hospital Olomouc, Vall d'Hebron Institute of Oncology, Université Catholique de Louvain, LMU Klinikum, Ludwig-Maximilians-Universität München, Newcastle upon Tyne Hospital, MorphoSys (Germany), Hospices Civils de Lyon, Claude Bernard University Lyon 1
Long-Term Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
